These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 36267789)

  • 1. Challenges, opportunities, and innovative statistical designs for precision oncology trials.
    Yin J; Shen S; Shi Q
    Ann Transl Med; 2022 Sep; 10(18):1038. PubMed ID: 36267789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early-Phase Platform Trials: A New Paradigm for Dose Finding and Treatment Screening in the Era of Precision Oncology.
    Polley MC; Cheung YK
    JCO Precis Oncol; 2019; 3():. PubMed ID: 32923846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology.
    Janiaud P; Serghiou S; Ioannidis JPA
    Cancer Treat Rev; 2019 Feb; 73():20-30. PubMed ID: 30572165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New clinical trial design in precision medicine: discovery, development and direction.
    Duan XP; Qin BD; Jiao XD; Liu K; Wang Z; Zang YS
    Signal Transduct Target Ther; 2024 Mar; 9(1):57. PubMed ID: 38438349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innovative trial design in precision oncology.
    Tsimberidou AM; Müller P; Ji Y
    Semin Cancer Biol; 2022 Sep; 84():284-292. PubMed ID: 33022355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of precision oncology basket and umbrella trials for clinicians.
    Park JJH; Hsu G; Siden EG; Thorlund K; Mills EJ
    CA Cancer J Clin; 2020 Mar; 70(2):125-137. PubMed ID: 32031692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Study Designs in Precision Medicine - Basket, Umbrella and Platform Trials.
    Ravi R; Kesari HV
    Curr Rev Clin Exp Pharmacol; 2022; 17(2):114-121. PubMed ID: 34455953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Light and shadow on innovative clinical trial designs: reflections from the EORTC-PAMM course on 'preclinical and early-phase clinical pharmacology'.
    Leonetti A; Boyd L; Giuliani J; Giovannetti E; Garajová I
    Expert Rev Clin Pharmacol; 2019 Nov; 12(11):1033-1036. PubMed ID: 31633383
    [No Abstract]   [Full Text] [Related]  

  • 9. Modified study designs to expand treatment options in personalised oncology: a multistakeholder view.
    Le Tourneau C; André F; Helland Å; Mileshkin L; Minnaard W; Schiel A; Taskén K; Thomas DM; Veronese ML; Durán-Pacheco G; Leyens L; Rufibach K; Thomas M; Krämer A
    Eur J Cancer; 2023 Nov; 194():113278. PubMed ID: 37820553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Umbrella and basket trials in oncology: ethical challenges.
    Strzebonska K; Waligora M
    BMC Med Ethics; 2019 Aug; 20(1):58. PubMed ID: 31443704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trial design in the era of precision medicine.
    Fountzilas E; Tsimberidou AM; Vo HH; Kurzrock R
    Genome Med; 2022 Aug; 14(1):101. PubMed ID: 36045401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarker-Driven Oncology Clinical Trials: Novel Designs in the Era of Precision Medicine.
    Moore DC; Guinigundo AS
    J Adv Pract Oncol; 2023 Apr; 14(Suppl 1):9-13. PubMed ID: 37206904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving Clinical Trial Efficiency: Thinking outside the Box.
    Mandrekar SJ; Dahlberg SE; Simon R
    Am Soc Clin Oncol Educ Book; 2015; ():e141-7. PubMed ID: 25993165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovation in oncology clinical trial design.
    Verweij J; Hendriks HR; Zwierzina H;
    Cancer Treat Rev; 2019 Mar; 74():15-20. PubMed ID: 30665053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical Considerations and Recommendations for Master Protocol Framework: Basket, Umbrella and Platform Trials.
    Lu CC; Li XN; Broglio K; Bycott P; Jiang Q; Li X; McGlothlin A; Tian H; Ye J
    Ther Innov Regul Sci; 2021 Nov; 55(6):1145-1154. PubMed ID: 34160785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Master Protocols for Precision Medicine in Oncology: Overcoming Methodology of Randomized Clinical Trials.
    Di Liello R; Piccirillo MC; Arenare L; Gargiulo P; Schettino C; Gravina A; Perrone F
    Life (Basel); 2021 Nov; 11(11):. PubMed ID: 34833129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New generation of breast cancer clinical trials implementing molecular profiling.
    Zardavas D; Piccart-Gebhart M
    Cancer Biol Med; 2016 Jun; 13(2):226-35. PubMed ID: 27458530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges with Novel Clinical Trial Designs: Master Protocols.
    Cecchini M; Rubin EH; Blumenthal GM; Ayalew K; Burris HA; Russell-Einhorn M; Dillon H; Lyerly HK; Reaman GH; Boerner S; LoRusso PM
    Clin Cancer Res; 2019 Apr; 25(7):2049-2057. PubMed ID: 30696689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Master protocol trials in oncology: Review and new trial designs.
    Hirakawa A; Asano J; Sato H; Teramukai S
    Contemp Clin Trials Commun; 2018 Dec; 12():1-8. PubMed ID: 30182068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Master protocols and other innovative trial designs in inflammation and immunology to expedite clinical drug development.
    Peeva E; Banerjee A; Banfield C; Soma K; Christensen J; Menon S; Vincent MS; Dolsten M
    Drug Discov Today; 2024 May; 29(5):103948. PubMed ID: 38460567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.